Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
about
The balance of powers: Redox regulation of fibrogenic pathways in kidney injurySpotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxideImpact of gestational bisphenol A on oxidative stress and free fatty acids: Human association and interspecies animal testing studies.Innate and Adaptive Immune Response in Fabry DiseaseDevelopment of a model system for neuronal dysfunction in Fabry disease.Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease.Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease.Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.Pathomechanisms of renal Fabry disease.Targeting Glycosphingolipid Metabolism to Treat Kidney Disease.Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
P2860
Q26786137-B7D118DC-704C-4EAD-A39C-3527514E7013Q27694770-75AF0B08-EC5E-4FDE-9457-FFC43A726233Q35088809-C9512A72-77AD-4E2A-B301-E0C86A633ACFQ35800976-E7791063-2981-4651-8705-8832FFBCCFABQ38754923-CB41E2F8-AFEB-4BEB-A5BB-673522B70971Q40351353-E5DFFE3D-C941-4DB3-8498-7C7FA77D5FCDQ41689988-415C7F42-904A-4998-8EEC-FD2362BC47B9Q47327376-CF911ABA-5910-467C-9B53-7B066625F44FQ48287690-246C698C-716E-4FB5-A8D0-21B140BB38DBQ55229542-A1B6635D-887F-4576-81FE-BE784F81CC17Q58691569-6D818937-59AE-44A5-BE0C-82CCD7F7F35AQ58777263-62DC6F73-BB91-44C8-A798-F470FEC4CDE2
P2860
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@ast
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@en
type
label
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@ast
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@en
prefLabel
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@ast
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
@en
P2093
P2860
P356
P1433
P1476
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease
@en
P2093
Anuradha Vivekanandan-Giri
Bouwien E Smid
Carla E M Hollak
James A Shayman
Liming Shu
Subramaniam Pennathur
P2860
P2888
P356
10.1038/KI.2013.520
P407
P50
P577
2014-01-08T00:00:00Z
P5875
P6179
1050668714